---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-096362"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-09-03T23:59:59+00:00"
generated_at: "2026-05-31T06:37:36.780478+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "medium"
source: SEC EDGAR
---

# Entero Therapeutics subsidiary receives default suspension, but no waiver

## Summary
- On August 29, 2024, ImmunogenX received letter from Lender Mattress Liquidators suspending MAE Default under Credit Agreement.
- Original Notice of Default was received on August 2, 2024, alleging Material Adverse Effect and accelerating all obligations.
- Lender's suspension is not a waiver; all rights regarding enforcement of MAE Default are expressly reserved.
- No principal amount or financial impact disclosed in filing; discussions are ongoing.

## SEC filing metadata
- accession: 0001104659-24-096362
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-09-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: medium
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/0001104659-24-096362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924096362/tm2423257d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-096362
- JSON: https://secwatch.observer/filing/0001104659-24-096362.json
- Plain text: https://secwatch.observer/filing/0001104659-24-096362.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.